LEP and endothelial dysfunction: These experimental and clinical studies indicate that the NO-dependent vasodilatory effects of leptin become impaired, and by this mechanism, leptin may contribute to endothelial dysfunction and the progression of atherosclerosis in patients with obesity and/or MetS.